3-Bromopyridine → Tert-butyl 1-(6-methylpyridazin-3-yl)azetidine-3-carboxylate
Reaction equation
Br[C:2]1[CH:3]=[N:4][CH:5]=[CH:6][CH:7]=1.[NH:8]1[CH2:11][CH:10]([C:12]([O:14][C:15]([CH3:18])([CH3:17])[CH3:16])=[O:13])[CH2:9]1.[NH:19]1CC(C(NC2C=CC(OC3CCN(C(OC(C)(C)C)=O)CC3)=CC=2)=O)C1>>[CH3:3][C:2]1[N:19]=[N:4][C:5]([N:8]2[CH2:9][CH:10]([C:12]([O:14][C:15]([CH3:18])([CH3:17])[CH3:16])=[O:13])[CH2:11]2)=[CH:6][CH:7]=1Participants
4
Procedure
The title compound was prepared as described in Example 1C, substituting 3-chloro-6-methylpyridazine for 3-bromopyridine and tert-butyl azetidine-3-carboxylate for tert-butyl 4-(4-(azetidine-3-carboxamido)phenoxy)piperidine-1-carboxylate.
Sources & evidence
- ORD record
- ord-9667ead9fee54d1a82f9ae008a6bc595
- Source dataset
- uspto-grants-2015_03
- Patent number
- US08975398B2
Reaction notes
Loading…